MedPath

瑞丽市畹町民鑫制药有限公司

Ownership
-
Established
1995-05-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

28

NMPA:28

Drug Approvals

GLUCOSE INJECTION

Product Name
葡萄糖注射液
Approval Number
国药准字H20217047
Approval Date
Jun 16, 2021
NMPA

GLUCOSE AND SODIUM CHLORIDE INJECTION

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20217046
Approval Date
Jun 11, 2021
NMPA

SODIUM CHLORIDE INJECTION

Product Name
氯化钠注射液
Approval Number
国药准字H20217044
Approval Date
Jun 3, 2021
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H53020143
Approval Date
Aug 28, 2020
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20083484
Approval Date
Aug 28, 2020
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H53020146
Approval Date
Aug 28, 2020
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H53020144
Approval Date
Aug 28, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H53020100
Approval Date
Aug 28, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H53020106
Approval Date
Aug 28, 2020
NMPA

Glucose and sodium chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H53020097
Approval Date
Aug 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy